Tumour necrosis factor-α antagonism: A potential therapeutic target for prevention of arrhythmogenesis in the setting of acute myocardial infarction?

Heart

Volumn 100, Issue 3, 2014, Pages 263-

  Yalta, Kenan ^a   Sivri, Nasir ^a   Geyik, Bilal ^a   Yetkin, Ertan ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ETANERCEPT; TUMOR NECROSIS FACTOR INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ARRHYTHMOGENESIS; CONGESTIVE HEART FAILURE; CYTOKINE RESPONSE; DISEASE ASSOCIATION; DRUG TARGETING; DRUG USE; ELECTROLYTE DISTURBANCE; FIBRINOLYSIS; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART RATE VARIABILITY; HEART TISSUE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HOSPITAL PATIENT; HUMAN; LETTER; LIFE THREAT; MORBIDITY; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCAR TISSUE; SUDDEN CARDIAC DEATH; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THERAPY EFFECT; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME; VASOMOTOR REFLEX; CARDIOVASCULAR EFFECT; HEART ATRIUM FIBRILLATION; PROTEIN TARGETING;

CARDIOVASCULAR SYSTEM; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; PLATELET ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84891799374     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-304338     Document Type: Letter

References (7)

1. Padfield GJ, Din JN, Koushiappi E, et al. Cardiovascular effects of tumour necrosis factor α antagonism in patients with acute myocardial infarction: a first in human study. Heart 2013;99:1330–5.
2. Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol 2012;60:2263–70.
3. Yalta K, Yılmaz MB, Turgut OO, et al. Markers of inflammation and thrombin generation: additional guides in determining the therapeutic strategy for malign ventricular arrhythmias after an acute myocardial infarction? Int J Cardiol 2010;145:492–3.
4. Elmas E, Hölzer L, Lang S, et al. Enhanced proinflammatory response of mononuclear cells to in vitro LPS-challenge in patients with ventricular fibrillation in the setting of acute myocardial infarction. Cytokine 2008;43:138–42.
5. Steptoe A, Molloy GJ, Messerli-Bürgy N, et al. Fear of dying and inflammation following acute coronary syndrome. Eur Heart J 2011;32:2405–11.
6. Shimoda Y, Satoh M, Nakamura M, et al. Activated tumour necrosis factor-alpha shedding process is associated with in-hospital complication in patients with acute myocardial infarction. Clin Sci (Lond) 2005;108:339–47.
7. Xiao H, Liao YH, Chen ZJ. Tumor necrosis factor-alpha: a new mechanism of ischemic ventricular fibrillation? Chin Med J (Engl) 2008;121:1848–51.